94 related articles for article (PubMed ID: 34046932)
41. Human papillomavirus E7 binds Oct4 and regulates its activity in HPV-associated cervical cancers.
Panayiotou T; Michael S; Zaravinos A; Demirag E; Achilleos C; Strati K
PLoS Pathog; 2020 Apr; 16(4):e1008468. PubMed ID: 32298395
[TBL] [Abstract][Full Text] [Related]
42. Genome-Wide Profiling of Cervical RNA-Binding Proteins Identifies Human Papillomavirus Regulation of RNASEH2A Expression by Viral E7 and E2F1.
Xu J; Liu H; Yang Y; Wang X; Liu P; Li Y; Meyers C; Banerjee NS; Wang HK; Cam M; Lu W; Chow LT; Xie X; Zhu J; Zheng ZM
mBio; 2019 Jan; 10(1):. PubMed ID: 30696738
[TBL] [Abstract][Full Text] [Related]
43. Piwil2 is reactivated by HPV oncoproteins and initiates cell reprogramming via epigenetic regulation during cervical cancer tumorigenesis.
Feng D; Yan K; Zhou Y; Liang H; Liang J; Zhao W; Dong Z; Ling B
Oncotarget; 2016 Oct; 7(40):64575-64588. PubMed ID: 27602489
[TBL] [Abstract][Full Text] [Related]
44. Retinoid status controls the appearance of reserve cells and keratin expression in mouse cervical epithelium.
Darwiche N; Celli G; Sly L; Lancillotti F; De Luca LM
Cancer Res; 1993 May; 53(10 Suppl):2287-99. PubMed ID: 7683571
[TBL] [Abstract][Full Text] [Related]
45. Immunohistochemical Evaluation of E6/E7 HPV Oncoproteins Staining in Cervical Cancer.
Stiasny A; Kuhn C; Mayr D; Alexiou C; Janko C; Wiest I; Jeschke U; Kost B
Anticancer Res; 2016 Jun; 36(6):3195-8. PubMed ID: 27272848
[TBL] [Abstract][Full Text] [Related]
46. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
[TBL] [Abstract][Full Text] [Related]
47. MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer.
Park S; Eom K; Kim J; Bang H; Wang HY; Ahn S; Kim G; Jang H; Kim S; Lee D; Park KH; Lee H
BMC Cancer; 2017 Sep; 17(1):658. PubMed ID: 28934937
[TBL] [Abstract][Full Text] [Related]
48. Human papilloma virus (HPV) E7-mediated attenuation of retinoblastoma (Rb) induces hPygopus2 expression via Elf-1 in cervical cancer.
Tzenov YR; Andrews PG; Voisey K; Popadiuk P; Xiong J; Popadiuk C; Kao KR
Mol Cancer Res; 2013 Jan; 11(1):19-30. PubMed ID: 23284001
[TBL] [Abstract][Full Text] [Related]
49. Human papillomavirus oncoproteins induce a reorganization of epithelial-associated γδ T cells promoting tumor formation.
Van Hede D; Polese B; Humblet C; Wilharm A; Renoux V; Dortu E; de Leval L; Delvenne P; Desmet CJ; Bureau F; Vermijlen D; Jacobs N
Proc Natl Acad Sci U S A; 2017 Oct; 114(43):E9056-E9065. PubMed ID: 29073102
[TBL] [Abstract][Full Text] [Related]
50. Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings.
Tezcan S; Ozgur D; Ulger M; Aslan G; Gurses I; Serin MS; Giray BG; Dilek S; Emekdas G
Asian Pac J Cancer Prev; 2014; 15(9):3997-4003. PubMed ID: 24935586
[TBL] [Abstract][Full Text] [Related]
51. Perturbation of DROSHA and DICER expression by human papillomavirus 16 oncoproteins.
Harden ME; Munger K
Virology; 2017 Jul; 507():192-198. PubMed ID: 28448850
[TBL] [Abstract][Full Text] [Related]
52. p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection.
Houghton O; Jamison J; Wilson R; Carson J; McCluggage WG
Histopathology; 2010 Sep; 57(3):342-50. PubMed ID: 20727021
[TBL] [Abstract][Full Text] [Related]
53. Prevalence of type-specific oncogenic human papillomavirus infection assessed by HPV E6/E7 mRNA among women with high-grade cervical lesions.
Wang HY; Park S; Lee D; Kim S; Kim G; Park KH; Lee H
Int J Infect Dis; 2015 Aug; 37():135-42. PubMed ID: 26141414
[TBL] [Abstract][Full Text] [Related]
54. miR-106a Regulates Cell Proliferation and Autophagy by Targeting LKB1 in HPV-16-Associated Cervical Cancer.
Cui X; Wang X; Zhou X; Jia J; Chen H; Zhao W
Mol Cancer Res; 2020 Aug; 18(8):1129-1141. PubMed ID: 32345599
[TBL] [Abstract][Full Text] [Related]
55. LKB1 inhibits HPV-associated cancer progression by targeting cellular metabolism.
Zeng Q; Chen J; Li Y; Werle KD; Zhao RX; Quan CS; Wang YS; Zhai YX; Wang JW; Youssef M; Cui R; Liang J; Genovese N; Chow LT; Li YL; Xu ZX
Oncogene; 2017 Mar; 36(9):1245-1255. PubMed ID: 27546620
[TBL] [Abstract][Full Text] [Related]
56. Requirement for stromal estrogen receptor alpha in cervical neoplasia.
Chung SH; Shin MK; Korach KS; Lambert PF
Horm Cancer; 2013 Feb; 4(1):50-9. PubMed ID: 23065599
[TBL] [Abstract][Full Text] [Related]
57. Progesterone signaling inhibits cervical carcinogenesis in mice.
Yoo YA; Son J; Mehta FF; DeMayo FJ; Lydon JP; Chung SH
Am J Pathol; 2013 Nov; 183(5):1679-1687. PubMed ID: 24012679
[TBL] [Abstract][Full Text] [Related]
58. Differential gene expression between skin and cervix induced by the E7 oncoprotein in a transgenic mouse model.
Ibarra Sierra E; Díaz Chávez J; Cortés-Malagón EM; Uribe-Figueroa L; Hidalgo-Miranda A; Lambert PF; Gariglio P
Virology; 2012 Nov; 433(2):337-45. PubMed ID: 22980503
[TBL] [Abstract][Full Text] [Related]
59. KNTC1, regulated by HPV E7, inhibits cervical carcinogenesis partially through Smad2.
Pan W; Wang S; Liu X; Wang M; Han X; Tian X; Lin J; Qiao X; Wang X
Exp Cell Res; 2023 Feb; 423(1):113458. PubMed ID: 36608837
[TBL] [Abstract][Full Text] [Related]
60. Cutaneous human papillomavirus E7 type-specific effects on differentiation and proliferation of organotypic skin cultures.
Westphal K; Akgül B; Storey A; Nindl I
Cell Oncol; 2009; 31(3):213-26. PubMed ID: 19478389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]